NIH holds state-of-the-science conference on multivitamin/mineral supplements, May 15 - 17, 2006

An impartial, independent panel will be charged with reviewing the available scientific evidence on the effectiveness and safety of multivitamin/mineral (MVM) supplement use for chronic disease prevention on May 15 -- 17. The panel will issue a statement of its findings on the final day of the conference, and will hold a press conference at 2:00 p.m. on Wednesday, May 17. Convened by the Office of Medical Applications of Research (OMAR) and the Office of Dietary Supplements (ODS) of the NIH, this conference is free and open to the public and the media.

Conference speakers' presentations, open discussions, and the panel's statement will focus on these questions:

1. What are the current patterns and prevalence of the public's use of MVM supplements?
2. What is known about the dietary nutrient intake of MVM users versus non-users?
3. What is the efficacy of single vitamin/mineral supplement use in chronic disease prevention?
4. What is the efficacy of MVM in chronic disease prevention in the general population of adults?
5. What is known about the safety of MVM for the generally healthy population?
6. What are the major knowledge gaps and research opportunities regarding MVM use?

Monday, May 15, 2006, 8:30 a.m. -- 5:00 p.m.
Tuesday, May 16, 2006, 8:30 a.m. -- 12:00 p.m.
Wednesday, May 17, 9:00 a.m. -- 11:00 a.m.
Press Conference: Wednesday, May 17, 2006, 2:00 p.m.

Natcher Conference Center
NIH Main Campus -- Building 45
9000 Rockville Pike
Bethesda, Maryland 20892

Campus visitor information: http://www.nih.gov/about/visitor/index.htm

The conference will also be webcast live at http://videocast.nih.gov/.
(Reporters viewing the press conference via webcast will be able to submit questions

Contact: Kelli Marciel
NIH/National Institutes of Health, Office of Disease Prevention

Page: 1 2

Related biology news :

1. AFCYBER holds science and technology symposium
2. Insulin grown in plants relieves diabetes in mice; UCF study holds promise for humans
3. Detecting transmissibility of avian influenza virus in human households
4. New research holds promise for protecting cancer patients against infertility
5. Canadian paper innovation holds promise for improved global health safety
6. Honey bee genome holds clues to social behavior
7. Research holds promise for herpes vaccine
8. The first tree genome is published: Poplar holds promise as renewable bioenergy resource
9. Receptor holds the key to mosquito immune response
10. North Poles ancient past holds lessons for future global warming
11. New lipid molecule holds promise for gene therapy

Post Your Comments:

(Date:1/29/2020)... (PRWEB) , ... January 29, 2020 , ... ... receptor and in vitro toxicology testing solutions, has announced a record earnings year ... upcoming weeks, INDIGO showed more than a twenty percent increase in revenue and ...
(Date:1/27/2020)... (PRWEB) , ... January 27, 2020 , ... ... as Chairman. Thorne is a noted investor, tech entrepreneur, and former senior management ... Executive Chairman of Broadline Capital, the global alternative investment firm. , “Chris ...
(Date:1/23/2020)... ... January 23, 2020 , ... GIOSTAR/HEAMGEN ... cells from stem cells. The red blood cells are made utilizing a ... conditions, for transfusion therapy and replaces the need for a human blood donor. ...
Breaking Biology News(10 mins):
(Date:2/5/2020)... ... February 05, 2020 , ... Rare Disease Day® , held ... National Organization for Rare Disorders (NORD), to raise awareness amongst the general public and ... The Balancing Act’s “Behind The Mystery” rare disease series will be shining ...
(Date:1/28/2020)... (PRWEB) , ... January 28, 2020 , ... ... Better Salivary Assay Kits . The new Salivary Total Human IgG ... “By measuring total immunoglobulin G in saliva, researchers can extend the accuracy and ...
(Date:1/24/2020)... ... 24, 2020 , ... Sierra Instruments, global leader in mass ... ideal for BioPharm OEMS. Sierra also announces RedyCompact™ flow meters ... employ high-precision MEMS (Micro-Electro Mechanical Systems) technology utilizing an advanced, ultra-stable no-drift CMOS ...
(Date:1/22/2020)... , ... January 21, 2020 , ... QCDx , ... biopsy from a simple blood draw, today announced the sale of the proprietary RareScope™ ... Rare Scope will be used in clinical cancer research. , “The RareScope can detect ...
Breaking Biology Technology:
Cached News: